Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 4;36(3):176-181.
doi: 10.1080/08830185.2017.1281272. Epub 2017 May 4.

MicroRNA-22-3p as a novel regulator and therapeutic target for autoimmune diseases

Affiliations
Review

MicroRNA-22-3p as a novel regulator and therapeutic target for autoimmune diseases

Bin Wang et al. Int Rev Immunol. .

Abstract

MicroRNAs (miRNAs) are a class of noncoding RNAs and have emerged as critical regulators of gene expression. Some miRNAs play important roles in regulating the function of the immune system and are involved in the pathogenesis of autoimmune diseases. Recent studies suggested that microRNA-22-3p (miR-22-3p) was able to regulate the function of several types of immune cells and may be involved in the development of autoimmune diseases. We systematically reviewed relevant literatures to provide a comprehensive review of the possible roles of miR-22-3p in autoimmune diseases. Published studies suggest that miR-22-3p can act as a novel regulator of autoimmune diseases via several pathways. More studies are needed to further elucidate the exact roles of miR-22-3p in autoimmune diseases. Treatment strategy targeting miR-22-3p is also a promising therapy for autoimmune diseases.

Keywords: Autoimmune diseases; microRNA-22-3p; pathogenesis; targeted therapy.

PubMed Disclaimer

Similar articles

  • The MicroRNA-21 in Autoimmune Diseases.
    Wang S, Wan X, Ruan Q. Wang S, et al. Int J Mol Sci. 2016 Jun 3;17(6):864. doi: 10.3390/ijms17060864. Int J Mol Sci. 2016. PMID: 27271606 Free PMC article. Review.
  • Cytokine Targeting by miRNAs in Autoimmune Diseases.
    Salvi V, Gianello V, Tiberio L, Sozzani S, Bosisio D. Salvi V, et al. Front Immunol. 2019 Jan 29;10:15. doi: 10.3389/fimmu.2019.00015. eCollection 2019. Front Immunol. 2019. PMID: 30761124 Free PMC article. Review.
  • MicroRNA-21 with therapeutic potential in autoimmune diseases.
    Xu WD, Pan HF, Li JH, Ye DQ. Xu WD, et al. Expert Opin Ther Targets. 2013 Jun;17(6):659-65. doi: 10.1517/14728222.2013.773311. Epub 2013 Mar 19. Expert Opin Ther Targets. 2013. PMID: 23506112 Review.
  • Role of microRNA-155 in autoimmunity.
    Leng RX, Pan HF, Qin WZ, Chen GM, Ye DQ. Leng RX, et al. Cytokine Growth Factor Rev. 2011 Jun;22(3):141-7. doi: 10.1016/j.cytogfr.2011.05.002. Epub 2011 Jun 23. Cytokine Growth Factor Rev. 2011. PMID: 21703910 Review.
  • Role of microRNA-155 in rheumatoid arthritis.
    Su LC, Huang AF, Jia H, Liu Y, Xu WD. Su LC, et al. Int J Rheum Dis. 2017 Nov;20(11):1631-1637. doi: 10.1111/1756-185X.13202. Epub 2017 Nov 3. Int J Rheum Dis. 2017. PMID: 29105307 Review.

Cited by

Publication types

LinkOut - more resources